Fresenius Kabi Usa
1 products tracked · names used in filings: Fresenius Kabi Usa
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Wed 29 Jul 2026🇺🇸 FDA approval
FDA approves Glycophos (sodium glycerophosphate): new active ingredient
Fresenius Kabi Usa; NDA220381; New active ingredient; solution · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Glycophos sodium glycerophosphate | Approved | 2026-07-29 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.